Datametrex Secures Another $450,000 COVID-19 Test Kit Purchase Order

The checks just keep on coming in for Datametrex AI (TSXV: DM). The company announced this morning that it has received yet another purchase order for COVID-19 test kits from a Canadian mining firm that has thousands of employees across numerous jurisdictions. This particular PO will be for operations within Ontario and Quebec.

Datametrex AI's Logo

This new order, from an unnamed Canadian miner, consists of 10,000 units of COVID-19 test kits manufactured by 1drop Inc. Also incliuded is an equal amount of swab kits, and two PCR detection system machines that are used to analyze samples. The gross sales figure from this single transaction amounts to $450,000, which will result in Datametrex showing significant quarterly sales growth.

Datametrex has already secured all of the requested equipment, which will be imported and distributed to the mining firm at their operations in Ontario and Quebec. Collectively, the two provinces account for more than 90% of Canadian COVID-19 cases, demonstrating the need for mining operators to take the necessary precautions to protect employees and operations as a whole.

Datametrex AI last traded at $0.12 on the TSX Venture.


FULL DISCLOSURE: Datametrex AI is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Datametrex AI on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Why $100 Silver Right Now Would Be a Problem | Keith Neumeyer – First Majestic

Why Industrial Demand Is Changing the Silver Market | David Morgan

Gold and Silver Delivery Is Exposing the Paper Market | Andy Schectman

Recommended

Why $100 Silver Right Now Would Be a Problem | Keith Neumeyer – First Majestic

The Court Ruling And What Emerita Still Has In Play | David Gower – Emerita Resources

Related News

Revive Announces Timeline For Phase 3 Studies, Sees Beneficial Psilocybin Developments

Revive Therapeutics (CSE: RVV) this morning announced that on the heels of receiving FDA approval...

Wednesday, August 5, 2020, 09:50:58 AM

Datametrex AI Enters Definitive Agreement To Acquire Concierge Medical Telehealth Platform

Datametrex AI (TSXV: DM) this morning announced that it has signed a definitive agreement to...

Friday, January 22, 2021, 07:12:19 AM

$16 Trillion Price Tag: US Economy Could Lose Nearly its Entire Annual Output Due to Pandemic

The US economy may be heading towards a significantly worse financial situation than previous estimates...

Monday, October 19, 2020, 03:52:18 PM

Datametrex Launches Nexalogy SMART AI-Based Technology

Datametrex AI Limited (TSXV: DM) subsidiary Nexalogy has launched its Social Media Automated Reporting Technologies...

Wednesday, December 9, 2020, 03:26:00 PM

Datametrex Begins Beta Testing Medi-Call App

Datametrex AI (TSXV: DM) is taking the next step with its telehealth app. The firm...

Tuesday, March 1, 2022, 08:22:20 AM